Publication: The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
Open/View Files
Date
2013
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Blackwell Publishing Ltd
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Greene, S. J., M. Gheorghiade, B. A. Borlaug, B. Pieske, M. Vaduganathan, J. C. Burnett, L. Roessig, et al. 2013. “The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction.” Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2 (6): e000536. doi:10.1161/JAHA.113.000536. http://dx.doi.org/10.1161/JAHA.113.000536.
Research Data
Abstract
Description
Other Available Sources
Keywords
cGMP, heart failure, phosphodiesterase 5, preserved ejection fraction, soluble guanylate cyclase
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service